Patient Handling Equipment Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 Market Research Future (MRFR) expects the patient handling equipment market to attain a valuation of USD 15,430.18 Million by 2027. MRFR also anticipates the market to thrive at a rate of 8.3% over the forecast period (2020-2027).

Key Players Locking Horns:

The patient handling equipment industry is rife with a number of players indulging in intense competition. Many of these companies are focused on carrying out extensive research and development activities to introduce new products that have multiple applications. Leading companies also adopt a number of organic as well as inorganic growth tactics, such as mergers & acquisitions, innovative product launches and expansions to enhance their share in the global industry.

Malvestio Spa (Italy), Stryker (US), Invacare Corporation (US), Handicare (Sweden), GF Health Products, Inc. (US), Arjo (Sweden), Joerns Healthcare LLC (US), Prism Medical UK (UK), McAuley Medical, Inc. (US), Etac AB (Sweden), EZ Way, Inc. (US), LINET (Czech Republic), Savaria (Canada), Medline Industries, Inc. (US), Ossenberg GmbH (Germany), Stiegelmeyer GmbH & Co. KG (Germany), Hill-Rom Services Inc. (US) are some of the most renowned vendors in the global market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9986 

Future Growth Boosters:

Governments are increasingly laying down guidelines and regulations pertaining to manual handling in healthcare, which are expected to be followed diligently and can help boost the demand for patient handling equipment in the near future. For instance, the National Institute of Occupational Safety & Health’s regulations with respect to the lifting equation with Recommended Weight Limit (RWL) help ensure that the patients are effectively handled, and the caregivers are not subjected to any risk of injury.

Furthermore, rising burden of disabilities worldwide combined with the growth of the elderly population prone to a number of disorders should foster the sales of patient handling equipment in the following years. The World Health Organization reported in 2014 that out of the total number of diseases in 2021, close to 1.18 million patients will be afflicted with some form of disability while the number by 2031 will reach 1.43 million patients. It is also expected that the frequent introduction of technical enhanced and safe device or equipment that are easy to operate by the caregivers, while also helping avoiding MSDs should work in the favor of the global market.

Segmentation:

Product, application and end-user are the top market segments listed in the MRFR report.

Product-based key segments are bathroom & toilet assist equipment, stretchers & transport chairs, ambulatory aids, patient transfer devices, wheelchairs & mobility scooters, medical beds, and others.  Patient transfer devices stand as the leading segment in the market on account of the growing prevalence of obesity worldwide. Meanwhile, medical beds are generating robust demand as well, with electric beds, semi-electric beds and manual beds gaining high traction.

Applications of patient handling equipment include mobility assistance, long term care, acute & critical care, and more. Acute & critical care segment is most likely to attain the top spot, in view of the significant increase in the rate of viral infections, cardiovascular diseases, and various acute diseases. Long term care segment can procure the fastest growth rate, owing to the significant burden of target diseases like tetanus, Alzheimer’s disease, tuberculosis, and others.

Major industry end-users are hospitals, home care settings and others. Hospitals segment is in the lead, in line with the developments in healthcare infrastructure along with the surge in healthcare spending.

Regional Status:

Europe, Americas, MEA or Middle East & Africa and Asia Pacific or APAC are the major regions that have been focused on in the MRFR report to analyze the growth prospects of the global market.

The lead has been taken by the American market, in view of the escalating obesity cases, in addition to various other chronic diseases. Heightened preference for home care equipment, expanding geriatric population, and favorable government aid in developing medical infrastructure can further benefit the patient handling equipment market in the region. Another growth rendering aspect has been the surge in musculoskeletal disorder rate in the region, which also bolsters the product demand.

Europe stands as the second most lucrative market for patient handling equipment, thanks to the significant number of research and development activities taking place in the region, backed by large-scale investments. Europe further benefits from the presence of a huge number of well-equipped medical facilities, skilled professionals, and the soaring demand for improved healthcare services. Supportive standards pertaining to patient safety and the surging prevalence of lifestyle and chronic diseases also add to the value of the patient handling equipment market in the region.

The APAC market should continue to soar rapidly and attain the fastest growth rate during the evaluation period. Some of the key growth boosters include the mounting cases of MSD-caused injuries, expanding older population and the improvement in the healthcare infrastructure. Substantial prominence of chronic ailments in the region also fosters growth. A number of countries have imposed policies regarding safe handling to avoid injury to caregivers while lifting patients. This has encouraged the adoption of patient handling equipment in the healthcare industry. Moreover, the fast economic growth of China, India, as well as Southeast Asia has prompted global players to invest significantly in this region, presenting attractive opportunities.

Latest Developments:

February 2021

Stryker, a reputed medical technology firm, has launched a wireless hospital bed series, ProCuity. The bed helps bring down the number of patient falls at every acuity level and bolster the nurse workflow safety as well as efficiency. The bed connects smoothly with the nurse call systems with no requirement for wires or cables. The medical bed is ergonomically developed with advanced technologies to promote intuitive positioning of the patient along with bed alarms and side rails.

Developments Post COVID-19 Outbreak

The entire healthcare sector has been deeply affected by the COVID-19 pandemic, resulting in weakened demand for patient handling equipment. The lockdown has lowered the workforce across the manufacturing units, leading to reduced production capacity. The novel coronavirus has also thrown challenges at the players in the form of revenue losses, debts, weaker supply chains, to name a few.

The accelerated cases of SARS-CoV-2 have compelled manufacturers to follow strict safety norms and maintain efficient communication, as employees’ health has become the key focus. It is also expected that the patient handling equipment industry can pick up pace in the coming years, backed by the surge in digitization in the healthcare industry.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/patient-handling-equipment-market-9986 

Research report covers the Medical Payment Fraud Detection Market Forecasts and Growth, 2020-2027

 Health fraud is an intentional deception or misrepresentation of fact that can result in unauthorized benefit or payment.

The growth of the medical payment fraud detection market is due to the unpredicted surge of healthcare scams and fraud during the COVID 19 outbreak, a rising number of patients opting for health insurance, and rising healthcare expenditure.

Furthermore, a large number of false or fake activities, increasing pressure of fraud and abuse on healthcare spending, and growing pressure to increase operational efficiency and reduce healthcare spending, are also expected to fuel the market during the forecast period.

However, the lack of skilled professionals and unwillingness to adopt the fraud analytics system in developing countries are expected to restrain the growth of the medical payment fraud detection market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9778 

Several market players such as SAS Institute, LexisNexis Risk Solutions, and Optuminsight, among others currently dominate the global medical payment fraud detection market.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2020, owing to the increasing number of patients opting for health insurances. For Instance, according to the Centers for Disease Detection and Prevention, in 2018 report, 25.5% people under age of 65 opted for public health insurance in the United States. The medical payment fraud detection market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European medical payment fraud detection market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, Italy, Spain, the UK and the rest of Western Europe. The medical payment fraud detection market in Asia-Pacific has been segmented into Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific. Due to large number of fraudulent activities, the market in Asia-Pacific is expected to be the fastest-growing. The medical payment fraud detection market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

Global Medical Payment Fraud Detection Market has been segmented based on the Type, Component, Delivery Model, Source of Services, and End User.

Based on Type, the global medical payment fraud detection market has been segmented into descriptive analytics, predictive analytics, and prescriptive analytics. Descriptive analytics forms the base for the effective application of predictive and prescriptive analytics.

On the basis of components, the market has been segmented into services and software. Software fraud detection is expected to hold a major market share.

Based on the delivery model, the market has been segmented into on-premise and cloud-based. The cloud-based fraud detection market is expected to gain traction during the forecast period.

On the basis of the source of service, the market has been segmented into in-house and outsourced.

The market based on end-user has been segmented into private insurance payers, public/ government agencies, and third-party service providers.

Key Players

Some of the key players in the global medical payment fraud detection market are LexisNexis Risk Solutions (US), International Business Machines Corporation (US), Optuminsight (US), OSP Labs (India), DXC Technology Company (US), UnitedHealth Group (US), SAS Institute (US), Fair Issac Corporation (US), EXL Service Holdings, Inc. (US), CGI GROUP (Canada).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medical-payment-fraud-detection-market-9778 

Research report covers the Microtome Market Forecasts and Growth, 2020-2027

 According to MRFR analysis, Microtome Market is expected to register a CAGR of 6.1% during the forecast period of 2019 to 2025 and accounts for USD 120 million in 2018.

A microtome is a tool used to cut extremely thin sections of tissue samples. Microtomes help in extremely fine cuts that are important for preparations used in microscopy. Different kinds of microtomes made up of metals and glass are used depending on the type of specimen and the desired thickness.

The growth of the global microtome market is driven by various factors such as an increase in the incidence of chronic disorders, increasing prevalence of lifestyle diseases, and increasing mergers & acquisitions by prominent players in the market. However, lack of skilled workforce is projected to hamper the growth of the global microtome market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8568 

The global microtome market is currently dominated by several market players such as Danaher Corporation, Thermo Fisher Scientific, and Sakura Finetek, among others. Additionally, growing growth strategies adopted by market players are driving the growth of the market. For instance, in 2018, Sakura Finetek launched Accu-Cut SRM 300 LT, manual microtome.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising per capita healthcare expenditure. The microtome market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European microtome market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The microtome market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing prevalence of chronic disorders and increasing patient pool, the market in Asia-Pacific is expected to be the fastest-growing. The microtome market in the Middle East & Africa has been bifurcated into the Middle East and Africa.

Segmentation

The Global Microtome Market has been segmented based on product, application, technology, and end-user.

The market, based on product, has been divided into instruments and accessories. Instruments are further sub-segmented into rotary microtomes, cryostat microtomes, vibrating microtomes, and others. Instruments are expected to hold the largest share, due to the commercial availability of these systems and their high adoption rate due to ease of handling.

In terms of application, the global microtome market has been segmented into disease diagnosis and medical research. Disease diagnosis takes up the largest share due to the increasing number of tissue examinations in research laboratories and hospitals owing to rising awareness about the benefits of early diagnosis of diseases like cancer.

In terms of technology, the global microtome market has been segmented into manual, semi-automated microtomes, and fully automated microtomes. The fully automated segment held the majority share due to rising demand for technologically advanced products and its ability to show the highest precision in section thickness. Additionally, fully automated microtomes do not require tedious manual adjustments.

In terms of end-user, the global microtome market has been segmented into hospital laboratories and clinical laboratories. Hospital laboratories take up the largest share. The positive growth of hospitals is attributed to factors such as a high volume of routine tissue examinations performed in hospital-based laboratories across the globe and growing patient population.

Key Players

Some of the key players in the Global Microtome Market are Amos Scientific Pty Ltd (Australia), Danaher (US), Diapath S.p.A. (Italy), Histo-Line Laboratories (Italy), Jinhua YIDI Medical Appliance Co., Ltd (China), MEDITE GmbH (Germany), Boeckeler Instruments, Inc. (US), Sakura Finetek (Japan), SLEE Medical GmbH (Germany), and Thermo Fisher Scientific (US)

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/microtome-market-8568 

Global Menopause Treatment Market Show Steady Growth: Study 2027

Global Menopause Treatment Market is expected to have a market value of USD 15,456.3 Million by 2027. Menopause causes uncomfortable symptoms, such as hot flashes, vaginal dryness, and weight gain and menopause treatments such as hormonal and non-hormonal treatments help to relieve these symptoms. Over the years, major market players in the menopause treatment are focusing on various growth strategies such as product launches, product advancements and expansions to cater to the growing needs for patients seeking treatment for menopause symptoms. For instance, in April 2019, Otsuka Pharmaceutical launched EQUELLE, a non-prescription, non-hormonal supplement to alleviate the frequency of hot flashes and muscle aches associated with menopause in the US. Such strategies push the demand for branded as well as generic menopausal drugs, thus promising huge growth for the industry.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4579 

Segment Analysis

The global menopause treatment market is segmented based on treatment and distribution channel.

The global menopause treatment market based on the treatment has been segmented into hormonal treatment and non-hormonal treatment. The hormonal treatment segment is further segmented into estrogen, progesterone, and combination. The non-hormonal treatment is further segmented into anti-depressants and others.

Based on distribution channel, the menopause treatment market is segmented into hospital pharmacies, retail pharmacies, and online stores.

Regional Analysis

The global menopause treatment market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa.

The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas led the market and accounted for the largest share in 2019 owing to the increasing product approvals and high uptake of new technology.  For instance, in July 2017, AMAG Pharmaceuticals, Inc. (US) launched Intrarosa (prasterone) for the treatment of moderate to severe dyspareunia a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Thus, such strategies employed by major players aid in the increased growth rate for the Americas menopause treatment industry.

The European menopause treatment market has been further segmented into Western Europe and Eastern Europe. The Western Europe menopause treatment market has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. Europe follows the Americas in the global menopause treatment market. The increasing inclination of companies towards female technology (femtech) is boosting the growth of the menopause treatment market in European countries. Many digital health start-ups have identified this opportunity and are offering B2C digital health tools, such as mobile apps, to guide menopausal women through this phase with lifestyle intervention tips and online telehealth consultations. As a result, the region is expected to show significant growth in the menopause treatment market.

The menopause treatment market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is expected to register the highest growth rate over the forecast period from 2020 to 2027. This is owing to the growing penetration of the women’s health sector, increasing awareness about the betterment of the women’s health, and the growing number of educational campaigns related to the benefits of hormone replacement therapy in China, Japan, India, and Australia.

The Middle East & Africa menopause treatment market is segmented Saudi Arabia, the United Arab Emirates (UAE), Oman, Kuwait, Qatar, and the rest of the Middle East & Africa. The negative connotation of menopause has resulted in a negative attitude towards menopause in premenopausal women. However, with the increasing awareness created by private companies, the scenario is expected to change in the next ten years.

Key Players

MRFR recognizes the following companies as the Key Players in the Global Menopause Treatment Market— Novo Nordisk A/S (Denmark), Pfizer Inc. (US), Allergan (Ireland), Eli Lily and Company (US), Emcure Pharmaceuticals Ltd (India), Novartis AG (Switzerland), Cipla Inc. (India), Teva Pharmaceuticals (Israel), Merck & Co., Inc. (US), Abbott Laboratories (US).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/menopause-treatment-market-4579 

Nebulizers Market Size, Share, Demand, Financial Overview, Key Developments, Swot Analysis and Forecast to 2027

 According to MRFR analysis, the Global Nebulizers Market is expected to register a CAGR of 7.32% during the forecast period of 2020 to 2027 and reach USD 1,629.7 Million by 2027.

A nebulizer is a type of breathing machine that is used to take inhaled medicines. Nebulizer treatment is carried out with an air compressor machine.

The growth of the global nebulizers market can be contributed to the growing need for rescue medication, high demand for respiratory devices, including nebulizers, due to outbreak of COVID-19 globally, and increasing prevalence of chronic respiratory diseases. According to a press release from Icon Plc in April 2020, the demand for respiratory devices has enormously increased, due to the rising cases of COVID-19.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9586 

Furthermore, the growing demand for home healthcare devices, rising geriatric population, increasing consumption of alcohol, tobacco, cigarettes, and other such products that might lead to respiratory diseases, are also expected to fuel the market growth during the forecast period.

However, the loss of drug during nebulization procedures, availability of various substitutes for nebulizers, and side effects of nebulizer solutions are expected to restrain the growth of the global nebulizers market.

Several market players such as OMRON Healthcare, Koninklijke Philips N.V., and B. Braun Melsungen AG, among others currently dominate the global nebulizers market. The key players are involved in awareness campaigns, product approvals, mergers, and strategic collaborations to strengthen their market positions. For instance, in April 2020, B. Braun Melsungen AG received the Food and Drugs Administration (FDA) emergency use authorization for using its infusion pumps with nebulizers to treat COVID-19 patients.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2019, owing to the rising demand for respiratory diseases in the region. The nebulizers market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European nebulizers market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The nebulizers market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing incidence rate of respiratory diseases, the market in Asia-Pacific is expected to be the fastest-growing. The nebulizers market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global Nebulizers Market has been Segmented Based on the Type, Usage, Portability, and End User.

Based on the Type, the global nebulizers market has been segmented into mesh, jet, and ultrasonic. The mesh segment is further divided into active and passive. The jet segment is expected to hold the largest market share owing to its low cost as compared to other types of nebulizers.

On the basis of usage, the market has been segmented into reusable and disposable. The disposable nebulizers are expected to hold a major market share owing to their growing popularity amongst the users.

Based on the portability, the market has been segmented into tabletop and portable. The portable nebulizers market is expected to grow at the fastest CAGR owing to its ease and convenience of use.

The market based on end-user has been segmented into hospitals & clinics, home care, and others. The hospitals and clinics segment is expected to hold the largest market share owing to the larger patient footfall in hospitals.

Key Players

Some of the key players in the global nebulizers market are OMRON Healthcare (Japan), Koninklijke Philips N.V. (Netherlands), PARI (US), Vectura Group plc (UK), Rossmax International Ltd (Taiwan), Briggs Healthcare (US), GF Health Products, Inc. (US), Beurer GmBH (Germany), Agilent Technologies, Inc. (US), Drive DeVilbiss Healthcare (US), Invacare Corporation (US), and B. Braun Melsungen AG (Germany).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/nebulizers-market-9586 

Global Electronic Trial Master File (eTMF) Systems Market Show Steady Growth: Study 2027

 According to MRFR analysis, Global eTMF Systems Market is expected to register a CAGR of 13.11% during the forecast period of 2019 to 2025 and anticipated to reach USD 1,825 Million by 2025.

The eTMF serves as a central repository to store and manage essential clinical trial documents and content for possible use in regulatory submissions. The eTMF software streamlines agency compliance with standards-based exports, and eSubmissions enables sharing between clinical trial stakeholders with language-independent taxonomy.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8772 

The growth of the global eTMF systems market is fueled by several factors such as rising activities in terms of acquisitions, new solution and service deployments, and collaborations by key players operating in the market, coupled with the increasing number of clinical trial studies. For instance, in October 2019, SureClinical Inc. launched a transparent eTMF pricing policy. To provide value to the prospective users, the company has posted its prices and terms online to battle price discrimination in this industry. However, budget constraints of the small and medium-sized enterprises, along with the dearth of skilled professionals for operating the electronic systems, can hinder the preference of such solutions. As a result, such elements can hamper the growth of the market during the forecast period.

Several market players currently dominate the global eTMF systems market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, in June 2018, Phlexglobal, a UK-based specialist provider of TMF and eTMF management solutions, is adopting Version 1 of the eTMF Exchange Mechanism Standard (eTMF-EMS) of the TMF Reference Model (TMF-RM) into PhlexEview, the company’s eTMF technology. Such strategies push the growth of the eTMF systems market.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas held the maximum share in the base year 2018, owing to the presence of established key players in countries such as the US and Canada. The eTMF systems market in the Americas has been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European eTMF systems market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The eTMF systems market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The eTMF systems market in this region is anticipated to be the fastest-growing during the assessment period due to the increased adoption rate of eTMF software and services in the Asian countries. The eTMF systems market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global eTMF Systems Market has been segmented based on Component, Deployment Mode, and End User.

The global eTMF systems market has been segmented, based on the component, into software and services. The software segment is expected to hold the majority share of the market owing to the increasing number of solution launches by the prominent players in recent years. The services segment is expected to be the fastest-growing due to the increasing uptake of eTMF services by pharmaceutical and life science companies.

The global eTMF systems market, based on deployment model, has been segmented into cloud/web-based, and on-premise. The cloud/web-based segment holds the maximum share owing to the technological advancements in cloud-based solutions in recent years.

The end-users of the market are pharmaceutical and biotechnology companies, contract research organizations, and others. The increasing number of clinical trials conducted by pharma firms is leading to the market size of the pharmaceutical and biotechnology companies’ segment.

Key Players

Some of the Key Players in the Global eTMF Systems Market are Aurea, Inc. (US), Covance Inc. (US), ePharmaSolutions (US), MasterControl, Inc. (US), Oracle (US), Phlexglobal (UK), SureClinical Inc. (US), TransPerfect (US), Veeva Systems (US), and Wingspan (IQVIA) (US).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/etmf-systems-market-8772 

Avian Influenza Vaccine Market Dynamics, Segments and Supply Demand 2020-2027

 Global Avian Influenza Vaccine Market is expected to register a CAGR of 7.25% during the forecast period, with a market value of USD 735.22 Million till 2025. Avian influenza or bird flu is an infection caused in birds due to the influenza type A virus. These viruses naturally occur among wild aquatic birds and can easily infect domestic poultry, other birds, and animal species.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8769 

Segment Analysis

The Global Avian Influenza Vaccine Market has been segmented by strain and application. The market, based on strain, has been bifurcated into H5, H7, and H9. Based on the application, the avian influenza vaccine market has been segregated into chicken, turkey, duck, and goose.

Regional Analysis

The Global Avian Influenza Vaccine Market, based on region, has been divided into the APAC & Middle East, Europe, Americas, and Africa.

The APAC & Middle East is likely to dominate the global avian influenza vaccine market. This can be attributed to the rise in avian influenza outbreaks and various government initiatives for the rapid and effective management of avian influenza in the region. According to a research study published in BioMedCentral in 2018, China, Vietnam, India, Taiwan, Israel, Japan, and South Korea have reported some of the largest outbreaks during the period of 2010–2016. Of these, the highest outbreaks were located in China (13.6%) in 2016. Moreover, high R&D expenditure invested by numerous key market players in the Asia-Pacific region is also expected to drive market growth.

The European market for the avian influenza vaccine is expected to be the second-largest during the review period. The collaborative initiatives of the government and private entities to promote improved animal health are expected to boost the growth of the regional market. For instance, the EU is working closely together with the World Health Organization, the Food and Agriculture Organization and the World Organization for Animal Health (OIE), in response to the global threat of avian flu. Additionally, the increasing production of veterinary products is also fueling market growth.

The Americas are estimated to be the fastest-growing market owing to the huge amount of animal welfare and veterinary/animal vaccine research-related activities in the region. For instance, the USGS Alaska Science Center has been a part of the State and Federal interagency team for the detection and response to highly pathogenic (HPAI) viruses in North America. Moreover, growing government support for creating awareness on avian influenza viruses and improving efficiency for the avian influenza vaccine is also positively affecting the market growth.

The market in Africa is expected to witness the lowest growth due to the limited access and availability of the avian influenza vaccine.

Key Findings of the Study

• The Global Avian Influenza Vaccine Market is estimated to reach USD 735.22 Million by 2025 at a CAGR of 7.25% during the assessment period

• The APAC & Middle East accounted for the largest share of the global avian influenza vaccine market due to the increasing prevalence of avian influenza

• Based on strain, the H5 segment accounted for the largest market share of 62.5% in 2018

• Based on application, the chicken segment accounted for the largest market share of 36.1% in 2018

Key Players

MRFR recognizes the following companies as the Key Players in the Global Avian Influenza Vaccine Market— Boehringer Ingelheim International GmbH (Germany), Guangdong Wenshi Dahuanong Biotechnology Co., Ltd (China), Ceva (US), Yebio Bioengineering Co., Ltd (China), Zoetis (US), FATRO S.P.A. (Italy), CAVAC (South Korea), Tianjin Ringpu Bio-Technology Co., Ltd (China), PT Japfa Comfeed Indonesia Tbk (Indonesia), Chengdu Tech-bank Biological Products Co., Ltd (China), Merck Animal Health (US), Medion (Indonesia), Avimex Animal Health (Mexico), JOVAC (Jordan), and QYH BIOTECH COMPANY LIMITED (China).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/avian-influenza-vaccine-market-8769